- Income Tax Expense (Benefit)
- Effective Income Tax Rate (EITR)
- Components of Deferred Tax Assets and Liabilities
- Deferred Tax Assets and Liabilities, Classification
- Adjustments to Financial Statements: Removal of Deferred Taxes
- Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
- Adjusted Net Profit Margin
- Adjusted Total Asset Turnover
- Adjusted Financial Leverage
- Adjusted Return on Equity (ROE)
- Adjusted Return on Assets (ROA)
Paying user area
Try for free
Merck & Co. Inc. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Merck & Co. Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Tax Expense (Benefit)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The income tax expense exhibited fluctuating behavior over the five-year period. A notable shift occurred between 2021 and 2022, followed by continued volatility through 2025. The components of the overall tax expense, namely the current and deferred provisions, demonstrate divergent trends contributing to this overall pattern.
- Current Provision
- The current provision for income taxes consistently increased from US$1,334 million in 2021 to US$4,475 million in 2025. This represents a substantial and steady upward trend, indicating a growing tax liability related to current taxable income. The increase was most pronounced between 2021 and 2022, with a subsequent, more moderate growth rate in subsequent years.
- Deferred Provision
- The deferred provision displayed a significantly different pattern. Beginning at US$187 million in 2021, it transitioned to a substantial negative value of -US$1,568 million in 2022. This negative trend continued, reaching -US$1,899 million in 2023, before moderating to -US$1,249 million in 2024 and -US$1,671 million in 2025. The consistent negative values suggest the recognition of deferred tax assets or the reversal of previously recognized deferred tax liabilities, potentially due to changes in tax laws or the utilization of tax loss carryforwards.
- Taxes on Income from Continuing Operations
- The total taxes on income from continuing operations initially decreased from US$1,521 million in 2021 to US$1,512 million in 2023. However, a significant increase was observed in 2024, reaching US$2,803 million, and remained relatively stable at US$2,804 million in 2025. This pattern largely reflects the offsetting effects of the current and deferred provisions. The increase in 2024 and 2025 is primarily driven by the rising current provision, despite the continued negative impact of the deferred provision.
The interplay between the current and deferred provisions significantly influences the overall tax expense. The increasing current provision suggests growing profitability subject to current tax rates, while the negative deferred provision indicates factors reducing the overall tax burden, such as the utilization of tax benefits or changes in deferred tax liabilities. The overall trend in taxes on income from continuing operations demonstrates a recent increase, despite the mitigating effect of the deferred provision.
Effective Income Tax Rate (EITR)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| U.S. statutory tax rate | ||||||
| Effective income tax rate |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The effective income tax rate exhibits significant fluctuation over the observed period. While the U.S. statutory tax rate remained constant at 21.00% throughout the years presented, the effective income tax rate demonstrates considerable variance.
- Effective Income Tax Rate Trend
- In 2021, the effective income tax rate was 11.00%. This increased modestly to 11.70% in 2022. A substantial increase is then observed in 2023, with the effective income tax rate reaching 80.00%. Following this peak, the rate decreased to 14.10% in 2024 and further declined to 13.30% in 2025.
The considerable divergence between the effective income tax rate and the statutory tax rate, particularly in 2023, suggests the presence of significant items impacting the company’s tax liability. These items could include tax benefits, one-time adjustments, changes in the geographic mix of earnings, or the impact of international tax regulations. The return towards rates closer to the statutory rate in 2024 and 2025 indicates a lessening influence of these factors, or a reversal of prior adjustments.
- Rate Differential
- The difference between the statutory and effective rates was 10.00% in 2021, 9.30% in 2022, 59.00% in 2023, 6.90% in 2024, and 7.70% in 2025. This highlights the substantial impact of non-statutory factors on the company’s overall tax burden, especially during 2023.
Further investigation into the components of income tax expense is warranted to understand the drivers behind the fluctuations in the effective income tax rate, particularly the exceptionally high rate observed in 2023. Understanding these drivers is crucial for accurate financial forecasting and assessing the sustainability of the company’s tax position.
Components of Deferred Tax Assets and Liabilities
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The composition of deferred tax assets and liabilities exhibits significant shifts over the five-year period. A notable increase is observed in both gross deferred tax assets and deferred tax liabilities, though the net effect transitions from a net liability to a net asset by 2023, before reverting to a net liability in subsequent years.
- Gross Deferred Tax Assets
- Gross deferred tax assets demonstrate a consistent upward trend, increasing from US$2,283 million in 2021 to US$7,557 million in 2025. The most substantial growth occurs between 2022 and 2024. This growth is primarily driven by increases in R&D capitalization, net operating loss and tax credit carryforwards, and ‘Other’ deferred tax assets. The valuation allowance against these assets also increases over time, offsetting some of the gross asset increase.
- R&D Capitalization
- R&D capitalization represents a rapidly growing component of deferred tax assets, rising from US$1,341 million in 2022 to US$4,134 million in 2025. This suggests an increasing level of investment in research and development activities, and the associated tax benefits of capitalizing those expenses.
- Net Operating Loss and Tax Credit Carryforwards
- Net operating losses and other tax credit carryforwards remain relatively stable between 2021 and 2023, fluctuating around US$867-912 million. A significant increase is then observed in 2025, reaching US$1,197 million, indicating a potential increase in taxable losses or the generation of new tax credits.
- Valuation Allowance
- The valuation allowance against deferred tax assets consistently increases throughout the period, from US$-287 million in 2021 to US$-824 million in 2025. This suggests a growing uncertainty regarding the realization of a portion of the deferred tax assets, potentially due to concerns about future profitability or changes in tax laws. The increasing valuation allowance partially mitigates the growth in gross deferred tax assets.
- Gross Deferred Tax Liabilities
- Gross deferred tax liabilities decrease from US$-4,745 million in 2021 to US$-2,840 million in 2023, before increasing again to US$-5,567 million in 2025. The primary driver of these liabilities is product intangibles and licenses, followed by accelerated depreciation.
- Product Intangibles and Licenses
- Product intangibles and licenses represent the largest component of deferred tax liabilities, and exhibit a substantial shift. Initially a significant liability, it decreases from US$-2,933 million in 2021 to US$-978 million in 2023, but then increases dramatically to US$-3,272 million in 2025. This fluctuation likely reflects changes in the valuation or amortization of these intangible assets.
- Pensions and Other Postretirement Benefits
- Both the asset and liability components related to pensions and other postretirement benefits demonstrate a decreasing trend. The deferred tax asset component declines from US$487 million in 2021 to US$117 million in 2025, while the liability component decreases from US$-338 million to US$-623 million over the same period. This suggests a reduction in the overall pension obligations or changes in related actuarial assumptions.
- Net Deferred Income Taxes
- Net deferred income taxes fluctuate considerably. A net liability of US$-2,749 million in 2021 decreases to a net asset of US$1,097 million in 2023, before reverting to a net liability of US$1,166 million in 2025. This volatility is a result of the combined changes in deferred tax assets and liabilities, and the valuation allowance.
Deferred Tax Assets and Liabilities, Classification
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Deferred income tax assets (included in Other assets) | ||||||
| Deferred income tax liabilities |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The deferred tax asset and liability positions exhibited significant fluctuations over the five-year period. A notable increase in deferred tax assets was observed alongside a decrease in deferred tax liabilities, suggesting evolving temporary differences between book and tax accounting.
- Deferred Tax Assets
- Deferred tax assets decreased from US$692 million in 2021 to US$503 million in 2022, representing a 27.3% decline. However, a substantial increase followed, with the asset balance rising to US$1,968 million in 2023 and further to US$3,601 million in 2024. A subsequent decrease to US$2,605 million was recorded in 2025. This pattern indicates potential changes in the realizability of deductible temporary differences or the utilization of existing tax loss carryforwards.
- Deferred Tax Liabilities
- Deferred tax liabilities demonstrated a consistent downward trend from 2021 to 2023. The balance decreased from US$3,441 million in 2021 to US$1,795 million in 2022, a decrease of 47.9%. This decline continued to US$871 million in 2023. A modest increase was then observed in 2024, with the liability reaching US$1,387 million, and a further increase to US$1,439 million in 2025. This suggests a reduction in taxable temporary differences over the period, followed by a stabilization and slight increase in later years.
The net deferred tax position (assets less liabilities) shifted considerably. In 2021, the net liability was US$2,749 million. By 2024, this had transformed into a net asset of US$2,214 million, before decreasing to US$1,166 million in 2025. This substantial change warrants further investigation into the underlying causes, such as alterations in tax laws, changes in accounting methods, or shifts in the nature of temporary differences.
The volatility in both deferred tax assets and liabilities suggests dynamic tax planning strategies or significant changes in the company’s business operations impacting its tax profile. The large increase in deferred tax assets in 2023 and 2024 should be examined for potential valuation allowance considerations.
Adjustments to Financial Statements: Removal of Deferred Taxes
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial information reveals adjustments made to reported figures, primarily concerning the removal of deferred tax assets and liabilities. These adjustments impact total assets, total liabilities, stockholders’ equity, and net income over the five-year period from 2021 to 2025. A consistent pattern emerges where adjusted figures differ from reported figures, suggesting a material impact from these tax-related adjustments.
- Total Assets
- Reported total assets generally increased from $105,694 million in 2021 to $136,866 million in 2025. However, adjusted total assets show a slightly lower, but similar, upward trend, ranging from $105,002 million in 2021 to $134,261 million in 2025. The difference between reported and adjusted assets remains relatively consistent across the period, indicating a systematic reduction due to the removal of deferred tax items. The largest absolute difference is observed in 2025, at $2,605 million.
- Total Liabilities
- Reported total liabilities fluctuated over the period, decreasing from $67,437 million in 2021 to $63,102 million in 2022, then increasing to $84,204 million in 2025. Adjusted total liabilities mirrored this trend, though generally at lower values, ranging from $63,996 million in 2021 to $82,765 million in 2025. The adjustments consistently reduce the reported liability figures, with the largest reduction occurring in 2025, amounting to $1,439 million.
- Stockholders’ Equity
- Reported stockholders’ equity exhibited volatility, increasing from $38,184 million in 2021 to $45,991 million in 2022, decreasing to $37,581 million in 2023, and then increasing again to $52,606 million in 2025. Adjusted stockholders’ equity followed a similar pattern, but with differing magnitudes. The adjustments generally increased equity in 2021 and 2022, decreased it in 2023, and increased it in 2024 and 2025. The largest adjustment to equity occurred in 2022, adding $1,292 million.
- Net Income
- Reported net income showed a substantial decrease in 2023 to $365 million, following increases in 2021 and 2022 ($13,049 and $14,519 million, respectively), before recovering to $17,117 million in 2024 and $18,254 million in 2025. The adjusted net income figures differ significantly, particularly in 2023, where it is reported as a loss of -$1,534 million, compared to the reported income of $365 million. Adjustments increased net income in 2021 and 2022, but substantially decreased it in 2023, and increased it in 2024 and 2025. The largest difference between reported and adjusted net income is observed in 2023, with a variance of $1,899 million.
The consistent adjustments to net income suggest that deferred tax items have a significant impact on the company’s reported profitability. The removal of these deferred taxes appears to reduce reported assets and liabilities, while having a variable effect on reported equity and a substantial effect on reported net income, particularly in 2023. Further investigation into the nature of these deferred tax items is warranted to understand the underlying reasons for these adjustments and their implications for the company’s financial performance and position.
Merck & Co. Inc., Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Deferred Taxes (Summary)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial performance metrics exhibit notable variations when deferred taxes are removed from the calculations. Generally, the adjusted ratios demonstrate a more conservative view of profitability and returns compared to the reported figures. Several key trends emerge across the five-year period.
- Profitability
- Reported net profit margin initially decreased from 26.79% in 2021 to 24.49% in 2022, then experienced a significant decline to 0.61% in 2023, before recovering to 26.68% and 28.08% in 2024 and 2025, respectively. The adjusted net profit margin follows a similar pattern, but the magnitude of the decline in 2023 is less pronounced, resulting in a negative value of -2.55%. This suggests that deferred taxes positively influenced reported profitability in 2023. The adjusted margin consistently remains below the reported margin, indicating a moderating effect from removing deferred tax impacts.
- Asset Efficiency
- Reported total asset turnover shows a gradual increase from 0.46 in 2021 to 0.56 in 2023, followed by a slight decrease to 0.55 in 2024 and a further decline to 0.47 in 2025. The adjusted total asset turnover mirrors this trend closely, with only minor differences in the reported values. This indicates that deferred taxes have a limited impact on the assessment of how efficiently assets are utilized to generate revenue.
- Financial Leverage
- Reported financial leverage decreased from 2.77 in 2021 to 2.37 in 2022, then increased to 2.84 in 2023, before decreasing again to 2.53 in 2024 and stabilizing at 2.60 in 2025. The adjusted financial leverage exhibits a similar pattern, though the values are generally lower than the reported figures. The removal of deferred taxes results in a slightly lower assessment of financial risk, as indicated by the reduced leverage ratios.
- Return on Equity (ROE)
- Reported ROE decreased from 34.17% in 2021 to 31.57% in 2022, experienced a dramatic drop to 0.97% in 2023, and then rebounded to 36.96% and 34.70% in 2024 and 2025. The adjusted ROE follows a similar trajectory, but the 2023 value is significantly negative (-4.20%). This substantial difference highlights the positive influence of deferred taxes on reported ROE during that year. The adjusted ROE consistently presents a more conservative view of returns to shareholders.
- Return on Assets (ROA)
- Reported ROA decreased from 12.35% in 2021 to 13.30% in 2022, then fell sharply to 0.34% in 2023, before recovering to 14.62% and 13.34% in 2024 and 2025. The adjusted ROA mirrors this pattern, with a negative value of -1.47% in 2023. Similar to ROE, the adjusted ROA provides a more subdued assessment of profitability relative to assets, particularly in 2023, due to the exclusion of deferred tax benefits.
In summary, the adjustments for deferred taxes generally lead to lower profitability and return ratios, particularly in 2023, suggesting a significant positive impact from deferred taxes on reported financial performance during that period. The asset efficiency and financial leverage ratios are less affected by these adjustments.
Merck & Co. Inc., Financial Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Net profit margin = 100 × Net income attributable to Merck & Co., Inc. ÷ Sales
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net income attributable to Merck & Co., Inc. ÷ Sales
= 100 × ÷ =
The period under review demonstrates considerable fluctuation in reported and adjusted net income, consequently impacting associated profit margins. While reported net profit margin exhibits relative stability with an upward trend towards the end of the period, the adjusted net profit margin presents a more volatile pattern.
- Reported Net Profit Margin
- Reported net profit margin decreased from 26.79% in 2021 to 24.49% in 2022. A significant decline occurred in 2023, falling to 0.61%. However, a substantial recovery is observed in 2024, reaching 26.68%, followed by a further increase to 28.08% in 2025. This indicates a strong rebound in profitability as measured by reported net income in the latter years of the period.
- Adjusted Net Profit Margin
- Adjusted net profit margin began at 27.18% in 2021, decreasing to 21.85% in 2022. A dramatic shift occurred in 2023, with the margin becoming negative at -2.55%. The margin then recovered to 24.73% in 2024 and continued to improve, reaching 25.51% in 2025. The negative value in 2023 suggests substantial adjustments were made to net income, significantly impacting profitability when considering these factors.
- Relationship between Reported and Adjusted Margins
- The divergence between reported and adjusted net profit margins is most pronounced in 2023. While reported net profit margin experienced a sharp decline, the adjusted margin became negative. This suggests that the adjustments made to arrive at adjusted net income in 2023 were particularly significant and negatively impacted profitability. The narrowing gap between the two margins in 2024 and 2025 indicates that the impact of these adjustments lessened as reported net income increased.
Overall, the analysis reveals a period of volatility, particularly concerning adjusted profitability. The substantial difference between reported and adjusted figures highlights the importance of understanding the nature of the adjustments made to net income when evaluating the company’s financial performance.
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Total asset turnover = Sales ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Sales ÷ Adjusted total assets
= ÷ =
The analysis reveals trends in both reported and adjusted total assets, alongside their corresponding turnover ratios, over a five-year period. Reported total assets generally increased from 2021 to 2025, with a slight decrease observed between 2021 and 2022, followed by consistent growth culminating in a substantial increase in 2025. Adjusted total assets mirrored this pattern, exhibiting similar fluctuations and overall growth.
- Adjusted Total Assets
- Adjusted total assets began at US$105,002 million in 2021 and rose to US$134,261 million in 2025. The largest year-over-year increase occurred between 2024 and 2025, suggesting a significant investment or revaluation of assets during that period. A minor decrease was noted between 2022 and 2023.
- Reported Total Asset Turnover
- Reported total asset turnover demonstrated fluctuation throughout the period. It increased from 0.46 in 2021 to 0.56 in 2023, then decreased slightly to 0.55 in 2024, and finally declined to 0.47 in 2025. This suggests a varying efficiency in generating sales relative to the company’s reported asset base.
- Adjusted Total Asset Turnover
- Adjusted total asset turnover followed a similar trend to the reported ratio. It increased from 0.46 in 2021 to 0.57 in 2023, remained stable at 0.57 in 2024, and then decreased to 0.48 in 2025. The adjusted ratio consistently remained at or above the reported ratio, indicating that adjustments to total assets provide a slightly more favorable view of asset utilization. The decline in both ratios in 2025 warrants further investigation to determine the underlying causes, such as potential sales slowdown or asset build-up.
The convergence of the reported and adjusted total asset turnover ratios suggests that the adjustments made to total assets do not significantly alter the overall interpretation of asset efficiency. However, the decrease in both ratios in the final year of the period indicates a potential decline in the effectiveness of asset utilization, which may require further scrutiny.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Financial leverage = Total assets ÷ Total Merck & Co., Inc. stockholders’ equity
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted total Merck & Co., Inc. stockholders’ equity
= ÷ =
An examination of the financial information reveals trends in total assets, stockholders’ equity, and associated leverage ratios over a five-year period. Both reported and adjusted total assets experienced fluctuations, while stockholders’ equity generally increased, though with some variability. The calculated financial leverage ratios, both reported and adjusted, remained relatively stable throughout the period.
- Total Assets
- Reported total assets increased from $105,694 million in 2021 to $109,160 million in 2022, then decreased to $106,675 million in 2023. A subsequent increase was observed in 2024, reaching $117,106 million, followed by a further increase to $136,866 million in 2025. Adjusted total assets mirrored this pattern, exhibiting similar fluctuations and overall growth.
- Stockholders’ Equity
- Reported total stockholders’ equity rose from $38,184 million in 2021 to $45,991 million in 2022. A decrease was then noted in 2023, falling to $37,581 million, before increasing again to $46,313 million in 2024 and $52,606 million in 2025. Adjusted stockholders’ equity followed a comparable trajectory, with a similar pattern of growth and decline.
- Reported Financial Leverage
- Reported financial leverage, calculated as total assets divided by total stockholders’ equity, began at 2.77 in 2021. It decreased to 2.37 in 2022, then rose to 2.84 in 2023. A slight decrease to 2.53 was observed in 2024, followed by a marginal increase to 2.60 in 2025. The ratio remained within a relatively narrow range throughout the period.
- Adjusted Financial Leverage
- Adjusted financial leverage exhibited a similar trend to the reported leverage ratio. Starting at 2.57 in 2021, it decreased to 2.30 in 2022, increased to 2.87 in 2023, decreased to 2.57 in 2024, and then slightly increased to 2.61 in 2025. The adjusted leverage ratio also demonstrated stability within a limited range over the five-year period.
The consistency between reported and adjusted figures suggests that the adjustments made did not materially alter the overall leverage profile. The slight fluctuations in leverage ratios appear to be driven by the combined effect of changes in total assets and stockholders’ equity.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROE = 100 × Net income attributable to Merck & Co., Inc. ÷ Total Merck & Co., Inc. stockholders’ equity
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net income attributable to Merck & Co., Inc. ÷ Adjusted total Merck & Co., Inc. stockholders’ equity
= 100 × ÷ =
The period between 2021 and 2025 demonstrates considerable fluctuation in reported and adjusted net income, impacting return on equity calculations. Reported net income experienced a significant decline in 2023 before recovering strongly in 2024 and 2025. Adjusted net income exhibited a similar pattern, with a substantial loss reported in 2023, followed by recovery in subsequent years. Stockholders’ equity, both reported and adjusted, generally increased over the five-year period, although with some volatility, particularly in 2023.
- Reported Return on Equity (ROE)
- Reported ROE began at 34.17% in 2021, decreased to 31.57% in 2022, and then experienced a dramatic drop to 0.97% in 2023, coinciding with the significant decline in reported net income. A substantial recovery was observed in 2024, with ROE reaching 36.96%, and this level was maintained relatively consistently in 2025 at 34.70%. The fluctuations in reported ROE closely mirror the changes in reported net income.
- Adjusted Return on Equity (ROE)
- Adjusted ROE followed a similar trend to reported ROE, starting at 32.34% in 2021 and decreasing to 27.39% in 2022. However, the adjusted ROE experienced a more pronounced decline in 2023, resulting in a negative value of -4.20%, reflecting the adjusted net loss for that year. A strong recovery occurred in 2024, with adjusted ROE rising to 35.98%, and it settled at 32.24% in 2025. The negative adjusted ROE in 2023 is a notable outlier.
- Relationship between Reported and Adjusted ROE
- The difference between reported and adjusted ROE remained relatively small in 2021 and 2022, suggesting that adjustments to net income had a limited impact on overall profitability metrics during those years. However, the divergence widened considerably in 2023, with the adjusted ROE being significantly more negative than the reported ROE, indicating that the adjustments had a substantial downward effect on profitability. This gap narrowed in 2024 and 2025 as both ROE metrics recovered.
- Stockholders’ Equity Trends
- Both reported and adjusted stockholders’ equity increased from 2021 to 2025, although not consistently. A decrease was observed in reported equity from 2022 to 2023, mirroring the decline in net income. Adjusted equity also decreased during the same period. The increases in equity in 2024 and 2025 likely reflect retained earnings from the improved net income performance.
Overall, the financial performance exhibited significant volatility during the analyzed period, particularly in 2023. The recovery in 2024 and 2025 suggests a return to more stable profitability, but the impact of adjustments to net income warrants further investigation.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROA = 100 × Net income attributable to Merck & Co., Inc. ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net income attributable to Merck & Co., Inc. ÷ Adjusted total assets
= 100 × ÷ =
The period between 2021 and 2025 demonstrates fluctuating performance when examining reported and adjusted return on assets. Reported net income exhibits volatility, initially increasing from 2021 to 2022, experiencing a substantial decline in 2023, and then recovering strongly in 2024 and 2025. Adjusted net income mirrors this pattern, though the magnitude of the 2023 decline is more pronounced, resulting in a negative value. Total assets, both reported and adjusted, generally trend upward over the five-year period, with a slight decrease in reported total assets in 2023.
- Reported Return on Assets (ROA)
- Reported ROA follows the trend of reported net income. It increases from 12.35% in 2021 to 13.30% in 2022, then drops significantly to 0.34% in 2023. A strong recovery is observed in 2024, reaching 14.62%, followed by a slight decrease to 13.34% in 2025. This suggests a strong correlation between net income and ROA, with asset levels remaining relatively stable in comparison.
- Adjusted Return on Assets (ROA)
- Adjusted ROA presents a similar, yet more dramatic, pattern. It begins at 12.61% in 2021, decreases to 11.92% in 2022, and then falls sharply to -1.47% in 2023. A substantial rebound occurs in 2024, reaching 13.98%, and then declines to 12.35% in 2025. The negative value in 2023 indicates that adjusted net income was insufficient to generate a return on adjusted assets during that year. The difference between reported and adjusted ROA suggests that certain adjustments significantly impact profitability assessment.
- Asset Trends
- Both reported and adjusted total assets generally increased throughout the period. Reported total assets grew from US$105,694 million in 2021 to US$136,866 million in 2025. Adjusted total assets followed a similar trajectory, increasing from US$105,002 million to US$134,261 million over the same period. The slight dip in both asset measures in 2023 coincides with the significant decline in net income, potentially indicating a period of asset restructuring or write-downs.
The divergence between reported and adjusted figures, particularly in net income and ROA, warrants further investigation to understand the nature and impact of the adjustments made. The substantial fluctuations in profitability, especially the negative adjusted ROA in 2023, highlight potential areas of concern and the importance of considering both reported and adjusted financial metrics when evaluating performance.